NEW YORK, Dec 18 - DNA Sciences said Monday it had entered an agreement to acquire PPGx, a pharmacogenomics products and services company, in an all stock deal.

In a statement DNA Sciences, which collects and studies DNA samples for disease-relevant SNPs, said that the combined companies would integrate their different scientific methodologies and research programs and pool patient sample collections.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.